HWAM
ONC icon

Hennion & Walsh Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Hennion & Walsh Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,721
Closed -$2.34M – 753
2021
Q1 		$2.34M Buy
+6,721
New +$2.23M 0.14% 200

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Hennion & Walsh Asset Management's ONC Position: Q2 2021 in Review

Hennion & Walsh Asset Management sold out of BeOne Medicines Ltd (ONC) in Q2 2021, closing a stake of 6,721 shares — an estimated $2.34M sold.

Hennion & Walsh Asset Management first reported a position in ONC in Q1 2021 and held it in 1 quarter. The position peaked at $2.34M in Q1 2021. 268 funds tracked by Wall St. Rank hold ONC as of Q2 2021.

  • Hennion & Walsh Asset Management reported no remaining BeOne Medicines Ltd position as of Q2 2021 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 6,721 BeOne Medicines Ltd shares in Q2 2021, an estimated $2.34M.
  • Hennion & Walsh Asset Management first reported a position in BeOne Medicines Ltd in Q1 2021 and held it in 1 quarter.
  • Hennion & Walsh Asset Management's BeOne Medicines Ltd position peaked at $2.34M in Q1 2021.
  • 268 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2021.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.